STOCK TITAN

Health Catalyst - HCAT STOCK NEWS

Welcome to our dedicated page for Health Catalyst news (Ticker: HCAT), a resource for investors and traders seeking the latest updates and insights on Health Catalyst stock.

Overview

Health Catalyst (HCAT) is an innovative provider of data and analytics technology and services tailored to healthcare organizations. The company is dedicated to enabling massive, measurable, data-informed improvement in patient care through its comprehensive suite of solutions that integrate advanced data warehousing, process improvement, and cloud-based analytics. Leveraging an adaptive data architecture and a late-binding bus framework, Health Catalyst delivers agile and flexible solutions that can be implemented rapidly compared to traditional models.

Core Capabilities and Business Model

At the heart of Health Catalyst’s business is its dual-segment model:

  • Technology Segment: This segment is the primary revenue driver and includes a cloud native data platform, a range of analytics applications, and extensive support services. The platform harnesses data from millions of patient records, normalizing and aggregating complex healthcare data to drive clinical, financial, and operational improvement. Its adaptive data model is designed specifically for the nuances of healthcare data, making it robust and scalable.
  • Professional Services Segment: Complementing the technology offerings, the professional services segment provides analytics, implementation, strategic advisory, outsourcing, and improvement services. This integrated approach ensures that healthcare organizations maximize the benefits of Health Catalyst’s technology by translating data insights into real-world care improvements.

Industry Significance and Technological Innovation

Health Catalyst is positioned firmly within the healthcare technology ecosystem, addressing significant challenges such as data interoperability, process inefficiency, and the unique regulatory demands of clinical data. The company leverages its adaptive data architecture—a solution born from years of healthcare veteran expertise—to overcome the limitations of traditional data models. By integrating advanced analytics, artificial intelligence, and cloud capabilities, Health Catalyst not only aids decision-making in clinical settings but also supports operational efficiency and revenue enhancement.

Partnerships and Strategic Acquisitions

Health Catalyst continuously strengthens its market position through strategic partnerships and acquisitions that reinforce its service portfolio. Recent collaborations include expanded relationships with health information exchanges to improve data interoperability across multi-state networks, as well as acquisitions in cybersecurity and patient engagement platforms. Such initiatives help the company provide an end-to-end data ecosystem that supports seamless clinical care, robust cybersecurity defenses, and enhanced patient engagement, ensuring a well-rounded and deeply integrated solution for healthcare organizations.

Operational Excellence and Market Position

The company’s offerings are characterized by their ability to be rapidly implemented, reducing the typical deployment time from months or years to mere weeks. This agility, combined with its comprehensive approach to data aggregation, normalization, and analytics, makes Health Catalyst a central player in helping healthcare providers make informed, data-driven decisions. Their technology is underpinned by decades of experience in clinical process improvement and data management, which informs every aspect of their product suite—from the cloud-based platform to the professional services that guide organizations in optimizing outcomes.

Technology, Integration, and Analytics

Health Catalyst’s ecosystem is built on a foundation of advanced technology:

  • Data Warehousing and Analytics Platform: Aggregates, normalizes, and enriches healthcare data from diverse sources using a proven, adaptive model.
  • Cloud-Based Solutions: Facilitates secure, scalable, and flexible access to data and analytics applications that overcome the limitations of traditional on-premises systems.
  • AI and Advanced Analytics: Integrates artificial intelligence and machine learning techniques to derive actionable insights that inform clinical and operational decisions.

This comprehensive approach ensures that healthcare data is both accessible and actionable, providing a competitive edge in an industry where timely and accurate information is critical.

Customer-Centric Approach

By combining technology with intensive professional expertise, Health Catalyst enables healthcare organizations to transition from data-heavy operations to insight-driven care delivery. The integrated nature of its solutions ensures that healthcare providers not only gain access to critical data, but also the expertise needed to analyze and implement changes that lead to improved patient outcomes, operational efficiency, and cost management.

Conclusion

In summary, Health Catalyst stands as a pivotal force in the convergence of data, technology, and healthcare improvement. Its adaptive data architecture, coupled with a broad array of analytics and professional services, positions it as an indispensable resource for healthcare organizations aiming to harness the power of data to drive clinical and operational excellence. The company’s commitment to integrating innovative technology with deep industry expertise makes it a noteworthy subject of analysis for investors and industry watchers seeking a comprehensive understanding of modern healthcare transformation.

Rhea-AI Summary

Health Catalyst (Nasdaq: HCAT) has completed its acquisition of Carevive Systems, a health technology company specializing in oncology. Carevive's platform is used for treatment care planning, clinical trial screening, care coordination, remote patient monitoring, and post-treatment care. This acquisition will enhance Health Catalyst's capabilities in oncology care and patient-reported outcomes. Both companies aim to leverage data and analytics to improve patient care and outcomes. The integration promises to deliver innovative solutions to cancer centers and provide researchers with valuable real-world data.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.19%
Tags
-
Rhea-AI Summary

Health Catalyst (Nasdaq: HCAT), a top provider of data and analytics technology in healthcare, announced its participation in key investor conferences. CFO Jason Alger and VP of Investor Relations Jack Knight will represent the company.

They will attend The Stifel Cross Sector Insight Conference in Boston, featuring a fireside chat on June 4, 2024, at 9:45am ET. Additionally, they will present at The Goldman Sachs 45th Annual Global Healthcare Conference in Miami, scheduled for June 12, 2024, at 8:40am ET.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.84%
Tags
conferences
-
Rhea-AI Summary

Health Catalyst (Nasdaq: HCAT) has launched Health Catalyst Ignite®, a next-generation data and analytics ecosystem designed for the healthcare sector. The platform integrates advanced technologies, healthcare-specific data models, self-service tools, and industry expertise to address the challenges of data management in healthcare. Ignite offers seamless integration, scalability, and flexibility, reducing costs and improving decision-making. It enables data sharing, centralizes data governance, and democratizes analytics to provide faster insights and enhanced control. The platform supports a range of healthcare use cases, from clinical improvement to operational efficiency, leveraging AI and machine learning for predictive insights.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.1%
Tags
none
Rhea-AI Summary

Health Catalyst, Inc. reported strong financial results for the first quarter of 2024, with total revenue of $74.7 million and Adjusted EBITDA of $3.4 million, beating guidance mid-points. The company remains focused on long-term profitability goals and reaffirmed its full-year guidance for 2024. Key metrics show growth in gross profit and margins, with a 1% increase in total revenue year over year. However, there was a 19% decrease in Adjusted EBITDA compared to the same period last year.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.9%
Tags
-
Rhea-AI Summary
Health Catalyst, Inc. will announce its first quarter 2024 operating results on May 9, 2024, after market close. The company will host a conference call to review the results at 5 p.m. E.T. on the same day.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.68%
Tags
-
Rhea-AI Summary
Health Catalyst, Inc. (HCAT) to participate in investor conferences with leadership members discussing key financial and strategic insights.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.85%
Tags
conferences
Rhea-AI Summary
Health Catalyst announces UnityPoint Health as the winner of the 2024 Flywheel Award for outstanding healthcare transformation achievements, showcasing significant cost savings and revenue enhancements through data and analytics.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.81%
Tags
none
-
Rhea-AI Summary
Health Catalyst's 2024 Healthcare Analytics Summit (HAS) in Salt Lake City gathers 1,000 global healthcare leaders to explore data and analytics in healthcare transformation. Keynotes by industry experts and sessions on AI, patient care, cost optimization, and more aim to drive innovation and impact.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.64%
Tags
none
-
Rhea-AI Summary
Health Catalyst, Inc. reports strong financial performance for 2023 with total revenue of $295.9 million and Adjusted EBITDA of $11.0 million, exceeding guidance. Leadership changes announced with Bryan Hunt transitioning to a Strategic Advisor role and Jason Alger appointed as CFO. Financial highlights show growth in Technology and Professional Services revenue.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.15%
Tags
none
Rhea-AI Summary
Health Catalyst, Inc. (HCAT) receives Quality Payment Program (QPP) Qualified Registry approval for 2024, enhancing its role in improving patient care and outcomes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.08%
Tags
none

FAQ

What is the current stock price of Health Catalyst (HCAT)?

The current stock price of Health Catalyst (HCAT) is $3.75 as of April 16, 2025.

What is the market cap of Health Catalyst (HCAT)?

The market cap of Health Catalyst (HCAT) is approximately 256.3M.

What is Health Catalyst's core business?

Health Catalyst provides data warehousing, analytics technology, and professional services designed to enable healthcare organizations to improve clinical and operational outcomes.

How does Health Catalyst generate revenue?

The company generates revenue primarily through cloud-based subscription contracts, licensing fees, and maintenance agreements within its technology segment, complemented by professional services contracts.

What makes Health Catalyst's data architecture unique?

Health Catalyst utilizes an adaptive data architecture based on a late-binding bus approach, tailored to handle the complexities of healthcare data with agility and flexibility.

Who are the likely customers of Health Catalyst?

Its customers include hospitals, health systems, physician practices, and health information exchanges that require comprehensive data integration and analytics solutions to drive quality improvement.

How does Health Catalyst support healthcare organizations beyond technology implementation?

In addition to its cloud-based solutions, Health Catalyst offers professional services that include analytics consulting, implementation support, strategic advisory, and process improvement to ensure maximum value extraction.

Which industry-specific challenges does Health Catalyst address?

The company tackles challenges such as data interoperability, complex clinical process modeling, cybersecurity, and efficient patient engagement, all within the context of evolving healthcare demands.

How does the company stay competitive in the healthcare technology market?

Through continuous innovation, strategic partnerships, and targeted acquisitions, Health Catalyst enhances its product offerings to address emerging challenges and maintain operational agility within the healthcare sector.

What role do partnerships and acquisitions play in Health Catalyst's strategy?

They are integral to expanding the company’s service portfolio and technological capabilities, enabling it to offer a more comprehensive solution that integrates cutting-edge analytics, cybersecurity, and patient engagement platforms.
Health Catalyst

Nasdaq:HCAT

HCAT Rankings

HCAT Stock Data

256.27M
67.17M
3.54%
76.54%
3.37%
Health Information Services
Services-computer Programming, Data Processing, Etc.
Link
United States
SOUTH JORDAN